Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure allows for selective modification in drug design, especially in creating analogs with improved metabolic stability. Commonly employed in medicinal chemistry for constructing cyclopropane-containing scaffolds that enhance binding affinity to specific receptors. Also utilized in research settings for preparing labeled compounds in metabolic and pharmacokinetic studies.